Li et al. showed that miR-3609 expression was lower in resistant cells (MDA-MB231 and MDA-MB468) than in more sensitive breast cancer cells (MCF-7), the exact opposite for PD-L1 expression. This evidence concerns the gene CD274 and breast carcinoma.